In Vitro Scaffold Construction for a Bio-artificial Liver by Webster, Brad et al.
 
 
 
 
 
 
 
 
 
 
 
 
In Vitro Scaffold Construction for a Bio-Artificial Liver 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BEE 453 
Tak Jong Kim, Brad Webster, Chrissy Tsai,  
Jeff Wang, Sharon Chow 
May 7, 2004 
 
    
In Vitro Scaffold Construction for a Bio-Artificial Liver 
BEE 453 
Tak Jong Kim, Brad Webster, Chrissy Tsai,  
Jeff Wang, Sharon Chow 
May 7, 2004 
 
Executive Summary: 
 
The main focus of this investigation is to design a scaffold that will accommodate a growing 
Bio-Artificial Liver (BAL) with oxygen.  The two design objectives are to find the maximum 
length and the distance between the artificial capillaries of the scaffold to provide adequate 
oxygen supply above 1.98 x 10
-19 g/um
3 to prevent hypoxia to the growing liver tissues.  By 
utilizing industrial modeling software, FIDAP and GAMBIT, a model of a single capillary with 
liver tissue attached directly was constructed to simulate the oxygen delivery by means of 
diffusion and convection from the capillary wall to the tissue and the uptake by metabolism.  
From the results obtained, it was concluded that diffusion, not convection of the oxygen flow 
within the capillary was the dominant process of oxygen transport throughout the tissue.  The 
maximum distance traveled into the tissue with capillary length of 60 µm was 147 µm from the 
capillary at the inlet side of the tissue while diffusion at the outlet tissue was at a modest 108 µm.  
These values are unacceptable for the feasible construction of oxygen transport system solely 
based on diffusion.  Thus, this investigation concludes that novel methods of greater complexity 
are needed to construct a more efficient and economically applicable oxygen delivery system for 
the mass production of bio-organs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction and Design Objectives: 
 
As of April 2004, there are a total of 90,438 patients on the waitlist for organ transplantation 
with waiting time that can take up to six years.  Further adding to the difficulty of receiving an 
organ from a donor, the organ transplantation availability depends on age, diagnosis, blood type, 
ethnicity, and other compatibility issues of both the patients and the donor.  Hence, the 
development of an artificial bio-organ is critical in the 21
st Century.   
 
A need to replace liver transplantation as a solution for acute liver failure exists since the 
unavailability of donor organs results in 30,000 deaths per year. The liver is among the 2
nd 
highest demand (17 000), following the kidney. Since liver cells have a high regenerative 
capacity and the graft survival rate for liver transplants are among the lowest, we find this high 
demand coupled with construction possibility for a Bio-Artificial Liver (BAL). Adhering to these 
principles, the design objective for this project will be to develop a system for the growth of a 
bio-artificial liver (BAL) in vitro. A vertical scaffold to simulate a network of capillaries will 
deliver oxygen among other nutrients to maturing liver cells. The proposed model is illustrated 
below in Fig.1.  
 
 
Figure1: Proposed scaffold capillary network for BAL design 
 
As nano-biotechnology further develops, diffusion-limited mass flow will have to be overcome 
to create more efficient nano-fabricated devices. These limits are seen in the field of tissue 
engineering in that oxygen delivery is limited to diffusion. Naturally, oxygen delivery in the 
body still relies on diffusion. However capillaries deliver oxygen to the tissue through the blood. 
As the blood goes through the capillary, oxygen diffuses into the surrounding tissue. Therefore 
since it still relies on diffusion capillaries cannot be spaced very far apart, otherwise hypoxia 
would ensue. Hypoxia is the deficiency of oxygen delivery, and a conservative value of 
60mmHg of oxygen was taken as the point where hypoxia begins.  
 
This project focuses on the oxygen delivery from the capillaries to the tissue of the proposed 
model (Fig.1).  Oxygen is essential to sustain metabolism in cells, and therefore, crucial to the 
design parameters of the scaffold. The tissue cells are modeled to surround the capillaries 
   directly, and the distance between the capillaries as well as the length of the capillaries is our 
main objectives for this investigation. By modeling the scaffold in GAMBIT and FIDAP, we can 
see how oxygen concentration varies along, and away from the capillary. We construct an axi-
symmetric model in cylindrical co-ordinates and add in factors including velocity of the oxygen-
carrying blood source at the capillary inlet, the diffusion rate in tissues as well as the metabolic 
reaction for oxygen consumption in the tissue. By taking the point where the level of hypoxia 
begins, and its distance away from the capillary inlet, we can then deduce the minimum distance 
between capillaries and the length of each network of capillaries.  
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Figure 2:  Model Schematics with proposed mesh and boundary conditions. 
 
 
 
 Results and Discussion: 
 
Quantitative Results 
 
  
Figure 3: Velocity Profile in the Capillary remains constant 
 
 
Figure 4:  Left Tissue concentration profile where hypoxia occurring at 147 µm 
 
    
Figure 5:  Right Tissue concentration profile where hypoxia occurring at 108 µm 
 
The velocity profile throughout the length of the capillary is laminar, parabolic flow.  This 
velocity profile can be seen in Fig 3, where the strongest flow is present at the bottom of the 
mesh, which represents the center of the capillary in an axi-symmetric model.   
 
In order to access the depth of O2 diffusion within the tissue, the left tissue, which represents the 
maximum amount of diffusion depth and the right tissue, which represents the minimum 
diffusion, is chosen.  Fig. 4, representing the left tissue, shows that hypoxia, which occurs at 1.98 
x 10
-19 g/um
3 of O2, occurs at 147µm away from the capillary.  Similarly, Fig.5 shows that 
hypoxia occurs at 108 µm away from the capillary at the right tissue.  By accessing the extremes, 
the minimum possible length of tissue between each adjacent capillaries of the scaffold was 
determined to be 108 µm.  In both cases, it is important to note that the capillary length was 60 
µm.   
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Figure 6: Results from original mesh 
 
Refined Mesh 
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Figure 7:  Results from refined mesh. 
    
The hypoxia level from the original mesh for the left side of the tissue was 147µm.  Fig. 6 
represents the species contour and the mesh for the unrefined mesh.  Fig. 7 represents the refined 
mesh.  Here the hypoxia level at the left side of the tissue was 140 µm.  The difference can be 
attributed to more nodes. 
 
Qualitative Explanation of Results 
 
Our model consists of blood, pre-saturated with oxygen from the lungs, flowing into a capillary 
surrounded by tissue of a constant density.  The modeled flow is parabolic in shape with the 
maximum velocity occurring at the center of the capillary and a velocity of zero at the capillary 
wall.  This goes against the common tube model known as the Haynes profile where the flow is 
tubular in form instead of parabolic.  Previous studies have shown that blood flow in capillaries 
tends to follow this tubular or trapezoidal form rather than parabolic.  This parabolic flow is 
assumed constant throughout the length of the capillary.  The flow model also ignores the 
possibility of red blood cells (RBC) stacking on top of each other in stacks known as Rouleux 
formations, and it ignores ‘tank treading’ that can occur if the RBC begin rotating as it flows.  
Therefore this leads to the major assumption of constant blood density.  Blood is indeed non-
Newtonian, but our model assumes that it behaves as a Newtonian fluid; which gives us the 
constant viscosity (at a hematocrit of 45). 
 
Our problem definition only concerns itself with the steady state solution.  The reasoning for this 
is that the tissue and capillary are always filled with blood and oxygen of a given concentration.  
The only time the non-steady state solution result would occur would be during development of 
the tissue and capillary themselves.  Therefore only the steady state solution is of interest.  Of 
course this solution would be subject to change for different flow rates such as would occur 
during strenuous exercise. 
 
The tissue in our model is allowing oxygen to diffuse into it from the capillary.  As the oxygen 
diffuses into the tissue, it is metabolically used up as the tissue performs metabolism to create 
ATP.  The model assumes a uniform tissue density composed of the same cells.  Therefore our 
reaction rate is constant.  Our reaction model also assumes the reaction is zero order.  Our model 
also assumes a constant diffusion of oxygen into the tissue, but in reality the behavior of 
hemoglobin would make this assumption unrealistic.  Hemoglobin loses oxygen at a nonlinear 
rate due to allosteric changes in the shape of the protein. 
 
Our model shows that diffusion is the dominant term over advection.  Therefore the model has 
oxygen diffusing out of the capillary only near the inlet instead of along the entire capillary.  The 
model shows that hypoxia is occurring towards the top of the mesh at about 147 um into the 
tissue.  Former research performed by Krogh gave a value of 250 um.  So our model is fairly 
consistent to this famous result.  Our sensitivity analysis will show that this value of 147 um is 
highly dependent on inlet concentration, capillary length, and our reaction rate.   
 
Sensitivity Analysis 
 To evaluate which parameters could influence oxygen transport significantly, we performed 
sensitivity analysis on capillary length, reaction rate, velocity, and diffusivity. Recall as under 
normal conditions, the distance from the capillary at which the concentration drops to 60 mmHg 
is 147 µm. Each parameter was altered +/- 15% and the distance from the capillary where 
hypoxia occurs (P = 60 mmHg, C = 1.98 E -19) at the left tissue (z = 0) was estimated. Results 
are listed and plotted below.  The results of sensitivity analysis are summarized in Table 1 and 
Fig. 8 for the four variables. 
 
            Table 1:  Sensitivity Analysis  
Parameter   % Deviation   Distance (µm)  
Length +15.00%  15 
Reaction 
Rate  -15.00%  R > 275 
 +15.00% 44.2 
    
Velocity  -15.00%  R > 275 
 +15.00% 105 
    
Diffusivity -15.00%  118 
  +15.00%  R > 275 
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Figure 8:  Spider Plot of Sensitivity Analysis 
 
For some of the parameters, the height where hypoxia occurs could not be determined because it 
was greater than 275 micrometers. It is noted that there is some uncertainty as to why there are 
asymmetrical influences about the mean and suggest that for further analysis to take incremental 
deviations less than 15%. From this analysis it is probable that the length of the capillary has a 
significant influence on the distance at which hypoxia occurs.  This is understandable as the 
capillary lengthens; it allows more oxygen to diffuse in the axial direction.  The next most 
sensitive parameter is the reaction rate; which confirms that oxygen concentrations depend on 
how fast cells are consuming resources. Diffusivity is not expected to change significantly and 
the velocity is not a dominant process in transport and thus does not alter results on a large scale.  
      
Discussion on Manufacturability, Sustainability, and Social Implications: 
If our design concept is to be made reality, several constraints that concern health and safety, 
manufacturing, and sustainability must be solved.  
  
The small dimensions of our design represent a manufacturing and sustainability challenge.   
Advancements in micro-fabrication techniques will aid in constructing channels to the required 
scale.  However, the walls of our scaffold must like a semi-permeable membrane with pores.  
Oxygen must be allowed to diffuse out into the tissue, while restricting blood or plasma to inside 
the capillary.  Carbon dioxide, a waste product of cellular metabolism, must be removed from the 
tissue in order to guarantee cell sustainability.  This kind of molecular separation has been 
demonstrated in environmental cleanup procedures but integrating this technology with micro-
fabrication may be complex. 
  
One of the most hotly debated aspects regarding the development of BAL devices surrounds the 
choice of cell types.  Choices have been narrowed down to human hepatocytes or porcine 
hepatocytes, each with their own intrinsic benefits and disadvantages.  From a sustainability 
standpoint, human hepatocytes grow poorly in cell media, making it difficult to accumulate 
enough cells to produce an effective BAL.  However, the bio-chemicals they produce are the 
same ones manufactured by a natural liver so the chance of immunity rejection is less.  Porcine 
hepatocytes are easier to grow and actually have shown a better ammonia clearing ability than 
human cells.  On the other hand, porcine cells do pose an increased health risks, as they are 
susceptible to porcine endogenous retroviruses. 
 
This project attempts the noble goal of solving the major problem health officials and patients 
face related to organ transplantation.  There are currently thousands of patients waiting for 
organs that must match their specific condition.  Not only must blood type match, but those that 
eventually receive the organ are unfortunately chosen based on age, wealth, and in many cases 
ethnicity.  The current system favors giving organs to those that can afford adequate health care, 
and elderly patients are usually overlooked in favor of younger patients.  Current statistics show 
that African-American male patients are the least likely to receive potential organs.  If this 
study’s ultimate goal were achieved artificial organs could help alleviate the major drain of 
resources that organ transplants now consume. 
 
Conclusion: 
Using FIDAP, we found the distance between capillaries for a scaffold designed to deliver 
oxygen to a Bio-Artificial liver.  The momentum and species equations were solved to find a 
steady state solution.  Based on the parameters utilized in the study, the channels must be at a 
range of 108-147 µm apart for optimum tissue growth when the capillary distance is 60 µm.  
Diffusion was found to be the primary factor in oxygen transport, rather than advection.  Thus, 
our original concept design consisting of long slender tubes needed to be changed.  Stacked 
layers consisting of short, thick capillaries (left) represent the ideal configuration for our model. 
  
 
 
 Future work remains on this project.  First, sensitivity analysis indicates that our results are 
highly dependent on the values of the constants used in the governing equations.  Further 
refinement is needed.  Secondly, several constraints affecting the health and safety, 
sustainability, and the scaffold’s manufacturing process must be considered. 
 
Figure 9:  Proposed Scaffold Model 
   Appendix A: Model Derivation and Assumptions  
 
A model of a single capillary attached to tissue was created to generate a simulation of the 
oxygen transport across the tissue bound by adjacent capillaries.  The model was simplified and 
only one capillary and its surrounding tissue was taken into consideration.   
 
The schematic of simplified two-capillary problem is as follows: 
 
 
 
 
 
 
 
 
Figure 10:  Hypothesized oxygen gradient between two adjacent 
capillaries with highest O2 concentration at the center of the capillaries 
 
Simplifying to a single capillary: 
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Figure 11:  Model Schematics with 
proposed mesh and boundary 
conditions.  5µm 
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60 µm Governing Equations 
 
For transport of oxygen: 
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For blood flow:  
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Boundary Conditions 
 
For z = 0 and z = 60  
(Left tissue and Right tissue) 
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Boundary at tissue and capillary: V = 0 
 
0 =
∂
∂
r
u
 in the capillary 
 
Ci = 1 concentration at the inlet of capillary 
 
Reaction Term: 
 
Zero
th
 – order reaction term that is a 
constant. 
 
 
 
Summary of Assumptions: 
1.  All capillaries have uniform geometry of a perfect cylinder of 5 micrometers.  
2.  All simulation proceeds within our defined constants of diffusivity and density.  
3.  The tissue is directly adjacent to the capillary with no other gaps in between.  
4.  The oxygen carrying fluid and tissue are assumed to have constant properties in terms 
of viscosity, density, flow-rate and inlet oxygen concentration. 
5.  There is no flow in r-direction but only in z-direction of fluid inside the capillary. 
6. Zero
th – order reaction for O2 metabolism by liver tissue. 
7.  Steady State Equation. 
8. Constant  O2 concentration at the inlet. 
9.  Rigid boundary layers. 
10. Axi-symmetric model. 
11. Laminar fluid flow inside the capillary.    
Appendix B: Mathematical Statements 
Table 2: Spreadsheet of all dimensional constants and their respective non-dimensional 
equivalents 
  Value (dimensional)  Value* (non-dimensional) 
Blood Density
1 1.06 x 10
-12 g/um
3  1 
Blood Viscosity
-2 5.94 x 10
-5 g/ um * sec  320215 
DiffusitivityTissue
4 1750 um
2/sec 1 
DiffusitivityCapillary
5 1060 um
2/sec .606 
Inlet Concentration
4 4.5 x 10
-18 g/um
3 (100 mmHg)  1 
Maximum Velocity
3 260 um/sec  .7429 
Reaction rate constant
5 -6.10 x 10
-21 g/um
3 * sec  -3.2 x 10
-5
Level till hypoxia
4 1.98 x 10
-19 g/um
3 (60 mmHg)  0.044 
 
Methods for making constants nondimensional*: 
Blood density* = Blood density = 1 
                   Blood density 
 
Characteristic length = 5 um 
 
Need variable u00 = Dcap = 1750/5 = 350 um/sec 
              L 
 
Blood viscosity* =       Blood viscosity     = 320215 
           (Blood dens.)(uoo)(L)                        
 
DiffusitivityTissue* =       DiffusitivityTissue  = 0.606 
     DiffusitivityCapillary
DiffusitivityCapillary* = DiffusitivityCapillary  = 1 
     DiffusitivityCapillary 
 
Inlet Concentration* = Inlet Concentration = 1 
     Inlet  Concentration 
 
Maximum Velocity* = Maximum Velocity = .7429 
    u 00
 
Reaction rate constant** = (Reaction rate constant)(L
2) = 1.44 x10
-22 g/um
3
      DiffusitivityTissue
 
Reaction rate constant* = Reaction rate constant** = -3.2 x 10
-5
                Inlet Concentration 
 
Level till hypoxia* =   Level till hypoxia = 0.044 
   Inlet  Concentration 
  (at this non-dimensional concentration on the concentration plots is where hypoxia occurs)    
Appendix C:  FIDAP Commands 
 
PROBLEM Command 
Axis-Symmetric (Geometry Type):  The capillary and tissue system was modeled as slab axis-symmetric. 
INCOMPRESSIBLE FLUID (FLOW REGIME): Fluid flow inside the capillary was modeled to be incompressible. 
STEADY STATE (SIMULATION TYPE): The problem can be assumed to be steady state due to the constant 
reaction term and inlet concentration that doesn’t change with time. 
LAMINAR (FLOW TYPE): Fluid flow inside the capillary is considered to be a laminar flow. 
NON-LINEAR (CONVECTIVE TERM): Convection was assumed to be non-linear inside the capillary 
MOMENTUM (MOMENTUM EQN): Fluid inside the capillary was modeled to be Newtonian. 
ISOTHERMAL (ENERGY EQN):  The solution was not dependent upon temperature. 
FIXED (SURFACE TYPE): The edges of the mesh were assumed to be stationary. 
NOSTRUCTURAL (STRUCTURAL SHAPE): The mesh is unstructured. 
NOREMESHING (ELASTICITY REMESHING): The mesh did not change shape during the simulation. 
SPECIES:  Oxygen Diffusion was the only species used in the mass equation. 
SINGLE PHASE (NUMBER OF PHASES): There were no phase changes. 
 
SOLUTION Command* 
SEGREGATION:  Set to 100 
VELOCITY CONVERGENCE: Set at 1.0E-2 
RESC: Set at 1.0E-1 
SOLUTION CHANGE: Set at 0 
RELAXATION: Set at 3, 3, 0, 5, 5, 0, 0, 0, 3, 3 
*Data provided by FIDAP consultant for convergence of velocity profile within the capillary 
 
PROB (AXI-, INCO, STEA, LAMI, NONL, NEWT, MOME, ISOT, FIXE, NOST, NORE,  
     SING, SPEC = 1.0 
PRES (MIXE = 0.100000000000E-15, DISC) 
EXEC (NEWJ) 
SOLU (SEGR = 100, VELC = 0.100000000000E-03, RESC = -0.100000000000E-02, 
       SCHA = 0.000000000000E+00) 
RELA (HYBR) 
   0.3000000000E+00, 0.3000000000E+00, 0.0000000000E+00, 0.5000000000E+00, 
   0.5000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.3000000000E+00, 0.3000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
ENTI (NAME = "Capillary", FLUI, MDEN = "capdens", MVIS = "capvisc", SPEC = 1.0, 
       MDIF = "capdiff") 
ENTI (NAME = "Tissue", SOLI, SPEC = 1.0, MDIF = "tissdiff", MREA = "metabolism") 
ENTI (NAME = "Axis", PLOT) 
ENTI (NAME = "Outlet", PLOT) 
ENTI (NAME = "Boundary", PLOT) 
ENTI (NAME = "Inlet", PLOT) 
ENTI (NAME = "Left Tiss", PLOT) 
ENTI (NAME = "Far Tissue", PLOT)    
ENTI (NAME = "Right Tissue", PLOT) 
DENS (SET = "capdens", CONS = 1.0) 
VISC (SET = "capvisc", CONS = 320215.0) 
DIFF (SET = "capdiff", CONS = 1.0) 
DIFF (SET = "tissdiff", CONS = 0.606) 
REAC (SET = "metabolism", CONS, TERM = 1, KINE) 
  -0.3200000000E-04, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00, 
   0.0000000000E+00, 0.0000000000E+00, 0.0000000000E+00 
BCNO (URC, ENTI = "Inlet", CONS = 0.000000000000E+00) 
BCNO (SPEC = 1.0, ENTI = "Inlet", CONS = 1.0) 
BCNO (VELO, ENTI = "Boundary", CONS = 0.000000000000E+00) 
BCNO (UZC, ENTI = "Inlet", POLY = 1, SYST = 1, CYLI) 
   0.7429000000E+00, -0.7429000000E+00, 0.2000000000E+01, 0.0000000000E+00, 
   0.0000000000E+00 
BCFL (SPEC = 1.0, ENTI = "Left Tiss", CONS = 0.000000000000E+00) 
BCFL (SPEC = 1.0, ENTI = "Far Tissue", CONS = 0.000000000000E+00) 
BCFL (SPEC = 1.0, ENTI = "Right Tissue", CONS = 0.000000000000E+00)   
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Postmortem: 
 
There were considerable difficulties in obtaining the solution.  However, the problem stemmed 
mostly from the initial simplification process of the model, and not on the program FIDAP itself.  
Most importantly, the conflicting results between our expected and actual results stumped the 
progress.  Initially, we predicted that convection by the fluid would be the major factor in 
transporting oxygen in the capillary, while diffusion is the dominant force once the oxygen 
reaches the liver tissue.  However, we obtained a very unique solution whereby the oxygen 
source at the inlet seemed to behave as a point source. 
 
After considerable work, we discovered that diffusion is the major force for the oxygen in the 
fluid, not convection of the moving fluid down the capillary.  Because the convection is minimal 
compared to the diffusion, all of the oxygen is diffused before the fluid has a chance to pull the 
oxygen down the capillary.  This result was a huge surprise that took us days to unravel. 
 
In light of understanding the result, the root of the problem was in the simplification of the 
problem.  In nature, the oxygen in the blood is not carried as diffusing species in the capillary.  
Instead, the oxygen is tightly bound to hemoglobin inside the red blood cells, and thus, this 
system prevents the straight diffusion as taking the dominant role of oxygen transport.  This 
hemoglobin release of oxygen is dependent on many factors that were not included in the 
simulation, such as the pH gradient, CO2 gradient and other physiological factors.  Hence, 
oxygen transport to targets far away can be accomplished, compared to 60 µm.  
 
In addition, sensitivity analysis shows that the results obtained are very sensitive to the constants 
and constraints placed upon our model.  Hence, accurate values must be experimentally 
determined.  Currently, there is a lack of research depth in tissue engineering, and thus, accurate 
values of liver density and liver tissue metabolic rate, for example, could not be obtained  
 
Overall, this project has showed us that what we see can be deceiving.  We should always be 
open to results that skew from the prediction and most importantly, if you check everything 
many times and there is nothing wrong with the input, there must be no problem with the output. 
 
 
 
     